Radioactive drugs tested to shrink tumors before prostate surgery
NCT ID NCT06881823
Summary
This study aimed to test two new radioactive drugs (AAA602 and AAA802) in men with high-risk prostate cancer that had not spread far. The drugs were given before surgery to remove the prostate, with the goal of killing more cancer cells and lowering the chance of the cancer coming back. The trial was designed to first find safe doses and then see if the drugs improved outcomes compared to having surgery alone, but the study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.